MPM Oncology Impact Management GP LLC
- SEC CIK
- 0001721035
No open-market purchases or sales filed in the past year.
Current role at each company
- CGEM Cullinan Therapeutics, Inc.10% Owneras of Aug 25, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists MPM Oncology Impact Management GP LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2021 (view filing)7:42 PM ET | Aug 23-25 | 2 days | MPM BioImpact LLC and 3 others10% Owner | SSale | −105.9K | $29.29 | −$3.10M | −1.3%7.81M after | 3 lots |
| Aug 12, 2021 (view filing)4:55 PM ET | Aug 11 | 1 day | MPM BioImpact LLC and 3 others10% Owner | SSale | −2.51K | $29.05 | −$72.9K | 0.0%7.91M after | Duplicate filing |